Effect of oral or transdermal hormone replacement therapy on homocysteine levels: A randomized clinical trial

Maturitas

Volumn 48, Issue 1, 2004, Pages 33-38

  Bruschi, F ^a   Dal Pino, D ^a   Fiore, V ^a   Parazzini, F ^a,d   Di Pace, R ^a   Cesana, B M ^b   Melotti, D ^c   Crosignani, P G ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c ICP   (Italy)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Homocysteine; Hormonal replacement therapy; Randomized clinical trial

Indexed keywords

ESTRADIOL; ESTRADIOL VALERATE; HOMOCYSTEINE; NORMEGESTROL ACETATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD LEVEL; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG FORMULATION; FEMALE; HORMONE SUBSTITUTION; HUMAN; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HOMOCYSTEINE; HUMANS; MIDDLE AGED; NORGESTREL; POSTMENOPAUSE; TREATMENT OUTCOME;

EID: 3042597553     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2003.08.005     Document Type: Article

References (12)

1. Boers G.H.J., Smals A.G.H., Trijbels J.M.F., Leermakers A.I., Kloppenborg P.W. Unique efficiency of methionine metabolism in premenopausal women may protect against vascular disease in the reproductive years. J. Clin. Invest. 72:1983;1971-1976
2. Wouters M.G., Moorees M.T., Van der Mooren M.J., et al. Plasma homocysteine and menopausal status. Eur. J. Clin. Invest. 11:1995;801-805
3. Mijatovic V., Kenemans P., Netelenbons J.C., et al. Postmenopausal oral 17β-estradiol continuously combined with dydrogesterone reduces fasting serum homocysteine levels. Fertil. Steril. 69:1998;876-882
4. Mijatovic V., Kenemans P., Jacobs C., Van Baal W.M., Peters-Muller E.R.A., Van der Mooren M.J. A randomized controlled study of the effects of 17β estradiol-dydrogesterone on plasma homocysteine in postmenopausal women. Obstet. Gynecol. 91:1998;432-436
5. Mijatovic V., Netelenbons J.C., Van der Mooren M.J., de Valk-de Roo G.W., Jakobs C., Kenemans P. Randomized, double blind, placebo-controlled study of the effects of raloxifene and conjugated equine estrogen on plasma homocysteine levels in healthy postmenopausal women. Fertil. Steril. 70:1998;1085-1089
6. Madsen J.S., Kristensen S.R., Klitgaard N.A., et al. Effect of long-term hormone replacement therapy on plasma homocysteine in postmenopausal women: a randomized controlled study. Am. J. Obstet. Gynecol. 187:2002;33-39
7. Van Baal W.M., Smolders R.G.V., Van der Mooren M.J., Teerlink T., Kenemans P. Hormone replacement therapy and plasma homocysteine. Obstet. Gynecol. 94:1999;485-491
8. Barnabei V.M., Philips T.M., Hsia J. Plasma homocysteine levels in women taking hormone replacement therapy: the postmenopausal estrogen/progestin intervention (PEPI) trial. J. Women Health Gend. Based Med. 8(9):1999;1167-1172
9. Evio S., Tiitinen A., Turpeinen U., Ylikorkala O. Failure of the combination of sequential oral and transdermal estradiol plus norethisterone acetate to affect plasma homocysteine levels. Fertil. Steril. 74:2000;1081-1083
10. Warnick G., Albers J. A comprehensive evaluation of the eparin-manganese precipitation procedure for estimating high-density lipoprotein cholesterol. J. Lipid. Res. 19:1978;65-76
11. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative of ultracentrifuge. Clin. Chem. 18:1972;499-502
12. van der Mooren M.J., Wounters M.G., Blom H.J., Schellekens L.A., Eskes T.K., Rolland R. Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women. Eur. J. Clin. Invest. 24:1994;733-736